On ECHEMI
Home > Drugs > Asthma
Asthma
Asthma is an episodic asthma disease caused by phlegm in the lungs, which is triggered by triggers or pathogens, resulting in phlegm blocking the airway, lung failure to descend, and phlegm and qi fighting. During an attack, there is wheezing in the throat, difficulty in breathing, and even inability to lie flat due to wheezing. Asthma is one of the common diseases in internal medicine, which is more common in northern my country. It is generally believed that the incidence of this disease accounts for about 2% of the population. Traditional Chinese medicine has accumulated rich experience in the treatment of this disease, with various methods and significant efficacy. It can not only relieve the symptoms during the attack, but also achieve the purpose of eliminating the root cause and controlling recurrence through strengthening the body. Although there is no name of asthma in the "Inner Canon of Medicine", there are records such as "wheezing" and "enough", which are similar to the characteristics of the attack of this disease. According to the definition and clinical manifestations of this disease, this disease is equivalent to bronchial asthma in Western medicine. Asthma caused by asthmatic bronchitis in Western medicine or other acute pulmonary allergic diseases can refer to the syndrome differentiation and treatment of this disease.
Related Drugs
Pingfeng Shengmai Capsule
Manufacturer:

Yunnan Chuxiong Yunzhong Pharmaceutical Co., Ltd.

Pingfeng Shengmai Capsule
Manufacturer:

Mianyang Yikang Pharmaceutical Co., Ltd.

Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Luan Worldbest Pharmaceuticals Co., Ltd.

Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Shijiazhuang No.4 Pharmaceutical Co., Ltd.

Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

Ambroxol Hydrochloride and Glucose Injection
Indication: 1. Applicable to acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma. 2. Preventive treatment of postoperative pulmonary complications. 4. Treatment of premature infants and neonatal respiratory distress syndrome (IRDS).
Manufacturer:

Lanxiha Sanlian Pharmaceutical Co., Ltd.

Benproperine phosphate oral solution
Indication: It is suitable for coughs caused by various reasons, especially irritating dry coughs, such as colds, pharyngitis, acute and chronic bronchitis, asthma, chronic obstructive pulmonary disease, smoking, allergies and other reasons.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.